Nearly a third of recovered COVID-19 patients return to hospital within five months – and up to one in eight die from complications from the disease, according to a report.
Researchers at the University of Leicester in the UK and the National Statistics Office found that of 47,780 people discharged from the hospital, 29.4 per cent were readmitted within 140 days, the Telegraph reported.
Of the total, 12.3% succumbed to the disease, she added.
Many people who suffer from long-term effects of coronavirus develop heart problems, diabetes and chronic liver and kidney disease, according to the report.
“People seem to go home, get long-term effects, come back and die. We see that almost 30 percent have been readmitted and that’s a lot of people. The numbers are so high, “said study author Kamlesh Khunti.
“The message here is that we need to prepare for long-term COVID. It’s a huge task to follow up on these patients, and the NHS is really pushing right now, but some kind of monitoring needs to be done, ”added Khunti, a professor of primary care diabetes and vascular medicine at the University of Leicester.
The study – which Khunti described as the largest number of people discharged from a hospital after being hospitalized with COVID-19 – found that survivors were almost 3 1/2 times more likely to be readmitted and dies in 140 days than other outpatients.
Khunti said the researchers were surprised that many people were readmitted with a new diagnosis, adding that it is important to make sure people are treated with protective therapies, including statins and aspirin.
“We don’t know if it’s because COVID destroyed the insulin-producing beta cells and you have type 1 diabetes or if it causes insulin resistance and you develop type 2, but we see these surprising new diagnoses of diabetes,” he said. said.
“We have seen studies in which survivors have had MRS scans and have heart and liver problems,” Khunti added. These people urgently need follow-up and the need to deal with things like aspirin and statins.
The new study was published on a prepress server and has not yet been evaluated by colleagues.
